The Korean Journal of Medicine

The Korean Association of Internal Medicine (대한내과학회)
권호 표지

The role of HbA1C testing in diagnosing diabetes

당뇨병 진단기준으로 헤모글로빈A1C의 역할

  • Lee, Hye-Jin (Department of Internal Medicine, Ewha Womans University School of Medicine)
  • 이혜진 (이화여자대학교 의학전문대학원 내과학교실)
  • Published : 2010.11.01
⟨ Previous Next ⟩

Abstract

Diabetes is often not diagnosed until complications appear, and approximately 30% of people with diabetes may be undiagnosed. Also, complications of diabetes have become a leading cause of impairment of life quality. Therefore efficient approaches to diagnosing diabetes should be developed. The most widely used test for diagnosis of diabetes includes fasting plasma glucose (FPG) and the oral glucose tolerance test (OGTT). The international expert committee has recently recommended the use of HbA1C assay to diagnose diabetes, with a threshold of ${\geq}$6.5%. In 2010, the American Diabetes Association (ADA) adopted the proposal and it became part of the diagnostic criteria of diabetes in the 2010 Clinical Practice Recommendations. Previously, HbA1C had been used primarily to monitor glycemic control among individuals with diabetes. However, over the last decade, the HbA1C measurement has become standardized, facilitating its recognition as an acceptable diagnostic method for diabetes. And several practical considerations favor the use of HbA1C in diagnosing diabetes. The HbA1C does not require the patient to be fasting, can be done at any time that a visit is scheduled, is simpler to perform than the 2 hr OGTT, and is less dependent on the patient's health status at the moment of the blood draw. Also HbA1C is less sensitive to several preanalytical variables, and biological variability is lower than that of both 2 hr post-load glucose and FPG. However, this advantage must be balanced by the low sensitivity of HbA1C, the limited standardization of HbA1C in certain regions, the incomplete correlation between HbA1C and glucose, and risk of misdiagnosis in patient with increased red blood cell turnover, end stage renal disease, with certain forms of hemoglobinopathies.

Keywords

References

  1. Jesudason DR, Dunstan K, Leong D, Wittert GA. Macrovascular risk and diagnostic criteria for type 2 diabetes: implications for the use of FPG and HbA(1c) for cost-effective screening. Diabetes Care 26:485-490, 2003 https://doi.org/10.2337/diacare.26.2.485
  2. International Expert Committee. International Expert Committee report on the role of the A1C assay in the diagnosis of diabetes. Diabetes Care 32:1327-1334, 2009 https://doi.org/10.2337/dc09-9033
  3. American Diabetes Association. Diagnosis and classification of diabetes mellitus. Diabetes Care 33(Suppl 1):S62-S69, 2010
  4. Kramer CK, Araneta MR, Barrett-Connor E. A1C and diabetes diagnosis: the rancho bernardo study. Diabetes Care 33:101-103, 2010 https://doi.org/10.2337/dc09-1366
  5. Carson AP, Reynolds K, Fonseca VA, Muntner P. Comparison of A1C and fasting glucose criteria to diagnose diabetes among U.S. adults. Diabetes Care 33:95-97, 2010 https://doi.org/10.2337/dc09-1227
  6. Cowie CC, Rust KF, Byrd-Holt DD, Gregg EW, Ford ES, Geiss LS, Bainbridge KE, Fradkin JE. Prevalence of diabetes and high risk for diabetes using A1C criteria in the U.S. Population in 1988-2006. Diabetes Care 33:562-568, 2010 https://doi.org/10.2337/dc09-1524
  7. Saudek CD, Herman WH, Sacks DB, Bergenstal RM, Edelman D, Davidson MB. A new look at screening and diagnosing diabetes mellitus. J Clin Endocrinol Metab 93:2447-2453, 2008 https://doi.org/10.1210/jc.2007-2174
  8. Petersen PH, Jorgensen LG, Brandslund I, De Fine Olivarius N, Stahl M. Consequences of bias and imprecision in measurements of glucose and hba1c for the diagnosis and prognosis of diabetes mellitus. Scand J Clin Lab Invest 240(Suppl):S51-S60, 2005
  9. Ollerton RL, Playle R, Ahmed K, Dunstan FD, Luzio SD, Owens DR. Day-to-day variability of fasting plasma glucose in newly diagnosed type 2 diabetic subjects. Diabetes Care 22:394-398, 1999 https://doi.org/10.2337/diacare.22.3.394
  10. Sacks DB. Global harmonization of hemoglobin A1c. Clin Chem 51:681-683, 2005 https://doi.org/10.1373/clinchem.2004.047431
  11. Bennett CM, Guo M, Dharmage SC. HbA(1c) as a screening tool for detection of Type 2 diabetes: a systematic review. Diabet Med 24:333-343, 2007 https://doi.org/10.1111/j.1464-5491.2007.02106.x
  12. Rohlfing CL, Wiedmeyer HM, Little RR, England JD, Tennill A, Goldstein DE. Defining the relationship between plasma glucose and HbA(1c): analysis of glucose profiles and HbA(1c) in the diabetes control and complications trial. Diabetes Care 25:275-278, 2002 https://doi.org/10.2337/diacare.25.2.275
  13. Nakagami T, Tominaga M, Nishimura R, Daimon M, Oizumi T, Yoshiike N, Tajima N. Combined use of fasting plasma glucose and glycated hemoglobin A1c in a stepwise fashion to detect undiagnosed diabetes mellitus. Tohoku J Exp Med 213:25-32, 2007 https://doi.org/10.1620/tjem.213.25
  14. Nakagami T, Tominaga M, Nishimura R, Yoshiike N, Daimon M, Oizumi T, Tajima N. Is the measurement of glycated hemoglobin A1c alone an efficient screening test for undiagnosed diabetes?: Japan national diabetes survey. Diabetes Res Clin Pract 76:251-256, 2007 https://doi.org/10.1016/j.diabres.2006.09.015
  15. Takahashi K, Uchiyama H, Yanagisawa S, Kamae I. The logistic regression and ROC analysis of group-based screening for predicting diabetes incidence in four years. Kobe J Med Sci 52:171-180, 2006
  16. Herman WH, Engelgau MM, Zhang Y, Brown MB. Use of GHb (HbA(1c)) to screen for undiagnosed diabetes in the U.S. population. Diabetes Care 23:1207-1208, 2000 https://doi.org/10.2337/diacare.23.8.1207
  17. Peters AL, Davidson MB, Schriger DL, Hasselblad V. A clinical approach for the diagnosis of diabetes mellitus: an analysis using glycosylated hemoglobin levels: meta-analysis research group on the diagnosis of diabetes using glycated hemoglobin levels. JAMA 276:1246-1252, 1996 https://doi.org/10.1001/jama.276.15.1246
  18. Barr RG, Nathan DM, Meigs JB, Singer DE. Tests of glycemia for the diagnosis of type 2 diabetes mellitus. Ann Intern Med 137:263-272, 2002 https://doi.org/10.7326/0003-4819-137-4-200208200-00011
  19. Wilson SE, Lipscombe LL, Rosella LC, Manuel DG. Trends in laboratory testing for diabetes in Ontario, Canada 1995-2005: a population-based study. BMC Health Serv Res 9:41, 2009 https://doi.org/10.1186/1472-6963-9-41
  20. Manley SE, Sikaris KA, Lu ZX, Nightingale PG, Stratton IM, Round RA, Baskar V, Gough SC, Smith JM. Validation of an algorithm combining haemoglobin A(1c) and fasting plasma glucose for diagnosis of diabetes mellitus in UK and Australian populations. Diabet Med 26:115-121, 2009 https://doi.org/10.1111/j.1464-5491.2008.02652.x
  21. Kim KS, Kim SK, Lee YK, Park SW, Cho YW. Diagnostic value of glycated haemoglobin HbA(1c) for the early detection of diabetes in high-risk subjects. Diabet Med 25:997-1000, 2008 https://doi.org/10.1111/j.1464-5491.2008.02489.x
  22. Buell C, Kermah D, Davidson MB. Utility of A1C for diabetes screening in the 1999 2004 NHANES population. Diabetes Care 30:2233-2235, 2007 https://doi.org/10.2337/dc07-0585
  23. Ginde AA, Cagliero E, Nathan DM, Camargo CA Jr. Value of risk stratification to increase the predictive validity of HbA1c in screening for undiagnosed diabetes in the US population. J Gen Intern Med 23:1346-1353, 2008 https://doi.org/10.1007/s11606-008-0661-6
  24. van't Riet E, Alssema M, Rijkelijkhuizen JM, Kostense PJ, Nijpels G, Dekker JM. Relationship between A1C and glucose levels in the general Dutch population: the new hoorn study. Diabetes Care 33:61-66, 2010 https://doi.org/10.2337/dc09-0677
  25. Icks A, Haastert B, Gandjour A, John J, Lowel H, Holle R, Giani G, Rathmann W. Cost-effectiveness analysis of different screening procedures for type 2 diabetes: the KORA survey 2000. Diabetes Care 27:2120-2128, 2004 https://doi.org/10.2337/diacare.27.9.2120
  26. Golembiewska E. Diagnostic value of fasting glucose, fructosamine, and glycated haemoglobin HbA(1c) with regard to ADA 1997 and who 1998 criteria for detecting diabetes and other glucose tolerance abnormalities. Ann Acad Med Stetin 50:131-138, 2004
  27. Lee H, Oh JY, Sung YA, Kim DJ, Kim SH, Kim SG, Moon S, Park IB, Rhee EJ, Chung CH. The role of HbA1C testing in diagnosing diabetes in Korean adults. European Association for the Study of Diabetes. 2010
  28. Lee H, Oh JY, Sung YA, Kim DJ, Kim SH, Kim SG, Moon S, Park IB, Rhee EJ, Chung CH, Kim BJ, Ku BJ. HbA1C for the diagnosis of diabetes in Korean adults. 8th International Diabetes Federation Western Pacific Region Congress 2010 Congress. 2010
  29. Coban E, Ozdogan M, Timuragaoglu A. Effect of iron deficiency anemia on the levels of hemoglobin A1c in nondiabetic patients. Acta Haematol 112:126-128, 2004 https://doi.org/10.1159/000079722
  30. Tarim O, Kucukerdogan A, Gunay U, Eralp O, Ercan I. Effects of iron deficiency anemia on hemoglobin A1c in type 1 diabetes mellitus. Pediatr Int 41:357-362, 1999